Log in

Relevant bibliographies by topics / Endocrinopathies / Journal articles

To see the other types of publications on this topic, follow the link: Endocrinopathies.

Journal articles on the topic 'Endocrinopathies'

Author: Grafiati

Published: 4 June 2021

Last updated: 26 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Endocrinopathies.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Sheely, Dana, and Deepti Pujare. "Endocrinopathies." Medical Clinics of North America 106, no. 3 (2022): 495–507. http://dx.doi.org/10.1016/j.mcna.2021.12.010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

VanArsdel, Paul P. "AUTOIMMUNE ENDOCRINOPATHIES." Immunology and Allergy Clinics of North America 13, no. 2 (1993): 371–94. http://dx.doi.org/10.1016/s0889-8561(22)00166-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Pearce, Simon H. S. "Autoimmune Endocrinopathies." Clinical Endocrinology 52, no. 2 (2000): 251. http://dx.doi.org/10.1046/j.1365-2265.2000.00927.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Moley, Jeffrey F., Terry C. Lairmore, and John E. Phay. "Hereditary endocrinopathies." Current Problems in Surgery 36, no. 9 (1999): 653–762. http://dx.doi.org/10.1016/s0011-3840(99)80001-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Gunn-Moore, Danièlle. "Feline endocrinopathies." Veterinary Clinics of North America: Small Animal Practice 35, no. 1 (2005): 171–210. http://dx.doi.org/10.1016/j.cvsm.2004.09.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Wong, LW, Nor Shaffinaz Yusoff Azmi Merican, Noor Rafhati Adyani Abdullah, Norasmidar Aziz, and Shartiyah Ismail. "ENDOCRINOPATHIES IN ADULT PATIENTS WITH TRANSFUSION-DEPENDENT THALASSEMIA IN HOSPITAL SULTANAH BAHIYAH." Journal of the ASEAN Federation of Endocrine Societies 38, S2 (2023): 35. https://doi.org/10.15605/jafes.038.s2.50.

Full text

Abstract:

INTRODUCTIONThalassaemia is the most common hereditary haematological disorder in Malaysia. Patients with transfusion-dependent thalassaemia (TDT) treated with frequent blood transfusion are typically at risk for developing multiple complications like endocrinopathies. Our primary objective is to determine the screening rate of endocrinopathies among our TDT patients. We also aimed to determine the prevalence of endocrinopathies and factors correlated with endocrinopathies. METHODOLOGYThis was a retrospective evaluation of all 113 patients with TDT who were under the care of the Haematology cl

APA, Harvard, Vancouver, ISO, and other styles

7

Ben Brahim, M., S. Daada, S. Tahri, et al. "Sarcoïdose et endocrinopathies." Annales d'Endocrinologie 82, no. 5 (2021): 384. http://dx.doi.org/10.1016/j.ando.2021.08.369.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Haissaguerre, M., and M. C. Vantyghem. "Lithium et endocrinopathies." Annales d'Endocrinologie 82, no. 5 (2021): 233. http://dx.doi.org/10.1016/j.ando.2021.07.044.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Karavitaki, N. "Opioids and Endocrinopathies." Annales d'Endocrinologie 82, no. 5 (2021): 230. http://dx.doi.org/10.1016/j.ando.2021.07.036.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Melmed, Shlomo. "Pituitary-Tumor Endocrinopathies." New England Journal of Medicine 382, no. 10 (2020): 937–50. http://dx.doi.org/10.1056/nejmra1810772.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Said El Mabrouk, R., N. Ghariani Fetoui, Y. Yousfi, et al. "Pelade et endocrinopathies." Annales d'Endocrinologie 85, no. 5 (2024): 450. http://dx.doi.org/10.1016/j.ando.2024.08.278.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Fountas, Athanasios, Stan Van Uum, and Niki Karavitaki. "Opioid-induced endocrinopathies." Lancet Diabetes & Endocrinology 8, no. 1 (2020): 68–80. http://dx.doi.org/10.1016/s2213-8587(19)30254-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Volpé, Robert. "The Autoimmune Endocrinopathies." Trends in Endocrinology & Metabolism 8, no. 2 (1997): 59–63. http://dx.doi.org/10.1016/s1043-2760(96)00267-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Fabien, Nicole. "Endocrinopathies auto-immunes." Bio Tribune Magazine 9, no. 1 (2004): 36–38. http://dx.doi.org/10.1007/bf03000518.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Sengupta, Pallav, Sulagna Dutta, Ivan Rolland Karkada, and Suresh V. Chinni. "Endocrinopathies and Male Infertility." Life 12, no. 1 (2021): 10. http://dx.doi.org/10.3390/life12010010.

Full text

Abstract:

Male infertility is approaching a concerning prevalence worldwide, and inflicts various impacts on the affected couple. The hormonal assessment is a vital component of male fertility evaluation as endocrine disorders are markedly reversible causatives of male infertility. Precise hormonal regulations are prerequisites to maintain normal male fertility parameters. The core male reproductive event, spermatogenesis, entails adequate testosterone concentration, which is produced via steroidogenesis in the Leydig cells. Physiological levels of both the gonadotropins are needed to achieve normal tes

APA, Harvard, Vancouver, ISO, and other styles

16

MASTROGIANNIS, DIMITRIOS S., VALERIE E. WHITEMAN, MICHAEL MAMOPOULOS, and WAEL A. SALAMEH. "Acute Endocrinopathies during Pregnancy." Clinical Obstetrics and Gynecology 37, no. 1 (1994): 78–92. http://dx.doi.org/10.1097/00003081-199403000-00012.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Jabbour, Serge A., and Jeffrey L. Miller. "Endocrinopathies and the skin." International Journal of Dermatology 39, no. 2 (2000): 88–99. http://dx.doi.org/10.1046/j.1365-4362.2000.00874.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Dev, Rony, Egidio Del Fabbro, and Shalini Dalal. "Endocrinopathies and cancer cachexia." Current Opinion in Supportive and Palliative Care 13, no. 4 (2019): 286–91. http://dx.doi.org/10.1097/spc.0000000000000464.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Cormier, Catherine. "Métabolisme phosphocalcique et endocrinopathies." Revue du Rhumatisme 67 (May 2000): 86–90. http://dx.doi.org/10.1016/s1169-8330(00)80083-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Siafakas, N. M., and D. Bouros. "Respiratory muscles in endocrinopathies." Respiratory Medicine 87, no. 5 (1993): 351–58. http://dx.doi.org/10.1016/0954-6111(93)90048-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Lewis, Catherine E., and Michael W. Yeh. "Inherited endocrinopathies: An update." Molecular Genetics and Metabolism 94, no. 3 (2008): 271–82. http://dx.doi.org/10.1016/j.ymgme.2008.03.006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Chen, Sue. "Pancreatic Endocrinopathies in Ferrets." Veterinary Clinics of North America: Exotic Animal Practice 11, no. 1 (2008): 107–23. http://dx.doi.org/10.1016/j.cvex.2007.09.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Klein, E., J. Brossaud, B. Gatta, and J. B. Corcuff. "Erythropoietin levels in endocrinopathies." Journal of Endocrinological Investigation 34, no. 6 (2011): 427–30. http://dx.doi.org/10.1007/bf03346707.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

AlHarbi, Atika, Majed Alshamrani, Mansoor Khan, Abdelmajid Alnatsheh, and Mohammed Aseeri. "Real-World Experience of Monitoring Practice of Endocrinopathies Associated with the Use of Novel Targeted Therapies among Patients with Solid Tumors." Medical Sciences 10, no. 4 (2022): 65. http://dx.doi.org/10.3390/medsci10040065.

Full text

Abstract:

Background: Cancer treatments have gradually evolved into targeted molecular therapies characterized by a unique mechanism of action instead of non-specific cytotoxic chemotherapies. However, they have unique safety concerns. For instance, endocrinopathies, which are defined as unfavorable metabolic alterations including thyroid disorders, hyperglycemia, dyslipidemia, and adrenal insufficiency necessitate additional monitoring. The aim of this study was to assess the prevalence of monitoring errors and develop strategies for monitoring cancer patients who receive targeted therapies. Method: A

APA, Harvard, Vancouver, ISO, and other styles

25

Vorotnikova, S. Y., and E. N. Andreeva. "Centre for Treatment of Pregnant Females with endocrinopathies." Bulletin of Reproductive Health 3, no. 2 (2024): 49–50. http://dx.doi.org/10.14341/brh12739.

Full text

Abstract:

This short message presents main information about Centre for Treatment of Pregnant Females with endocrinopathies. The aim of the present Centre is organization planning and dynamic control of pregnancy for females with endocrinopathies.

APA, Harvard, Vancouver, ISO, and other styles

26

Chang, Lee-Shing, Romualdo Barroso-Sousa, Sara M. Tolaney, F. Stephen Hodi, Ursula B. Kaiser, and Le Min. "Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints." Endocrine Reviews 40, no. 1 (2018): 17–65. http://dx.doi.org/10.1210/er.2018-00006.

Full text

Abstract:

Abstract Immune checkpoints are small molecules expressed by immune cells that play critical roles in maintaining immune homeostasis. Targeting the immune checkpoints cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed death 1 (PD-1) with inhibitory antibodies has demonstrated effective and durable antitumor activity in subgroups of patients with cancer. The US Food and Drug Administration has approved several immune checkpoint inhibitors (ICPis) for the treatment of a broad spectrum of malignancies. Endocrinopathies have emerged as one of the most common immune-related adverse

APA, Harvard, Vancouver, ISO, and other styles

27

Mokrysheva, Natalia G., Gagik R. Galstyan, Michael A. Kirzhakov, Anna K. Eremkina, Ekaterina A. Pigarova, and Galina A. Melnichenko. "COVID-19 pandemic and endocrinopathies." Problems of Endocrinology 66, no. 1 (2020): 7–13. http://dx.doi.org/10.14341/probl12376.

Full text

Abstract:

Many endocrinopathies have chronic course; patients with endocrinopathies (above all diabetes mellitus and thyroid diseases) who receive outpatient care on a regular basis amount up to 80% of patients with chronic diseases. Endocrinologists most likely play the role of general practitioners for these patients; therefore, they should quickly and efficiently explain the patients with diabetes, thyroid, hypophysis and adrenal diseases how to behave in new setting of COVID19 pandemic (coronavirus infection). The most severe course of the infection can be observed in patients older than 65 years wi

APA, Harvard, Vancouver, ISO, and other styles

28

Awad, Hala, E. Eva Culakova, Umanj Gada, et al. "318 Immune checkpoint inhibitor-induced endocrinopathies in a large prospective cohort of Black and White cancer patients." Journal of Clinical and Translational Science 9, s1 (2025): 97–98. https://doi.org/10.1017/cts.2024.950.

Full text

Abstract:

Objectives/Goals: Knowledge about predictive factors for immune-related endocrinopathies can help identify appropriate populations for specific screening approaches, provide recommendations for ICI therapy selection, guide clinical monitoring strategies to improve patient outcomes, and guide research efforts to provide equitable healthcare for all patients. Methods/Study Population: This is an analysis of the demographic and clinical data available of patients from DiRECT Cohort, a longitudinal study that prospectively follows adult cancer patients who self-identify as Black or White and under

APA, Harvard, Vancouver, ISO, and other styles

29

Haq, Tahniyah, Shapur Ikhtaire, Farzana Rahman, and Nishat Nayla Aurpa. "Endocrinopathies in thalassemia - a review." IMC Journal of Medical Science 15, no. 1 (2021): 47–55. http://dx.doi.org/10.3329/imcjms.v15i1.54202.

Full text

Abstract:

Improved treatment has increased survival of patients with thalassemia. However, they still suffer from several endocrine complications mainly as a result of iron overload from multiple transfusions. Endocrinopathies manifest as early as the first decade of life, affecting growth, puberty, psychological development and quality of life. The presence of concomitant anemia, chronic liver disease and cardiomyopathy affect the development and treatment of endocrine disorders, making endocrinopathies in thalassemia a complex disorder. This review focuses on the pathogenesis, diagnosis and treatment

APA, Harvard, Vancouver, ISO, and other styles

30

Tzoulis, Ploutarchos. "Review of Endocrine Complications in Adult Patients with β-Thalassaemia Major". Thalassemia Reports 4, № 3 (2014): 4871. http://dx.doi.org/10.4081/thal.2014.4871.

Full text

Abstract:

Endocrine abnormalities are amongst the most common complications of β-thalassaemia major (TM). This is an overview of endocrinopathies of adult patients with β-thalassaemia major, excluding osteoporosis and fertility issues. This review will focus on emerging evidence in the last 5 years with regards to endocrinopathies in patients with TM.

APA, Harvard, Vancouver, ISO, and other styles

31

AHMAD AKBAR, ROSDINA ZAMRUD, Sharifah Faradila WM Hatta, Rosnida Mohd Noh, et al. "ENDOCRINOPATHIES IN HIV INFECTED PATIENTS." Journal of Clinical and Health Sciences 5, no. 2 (2020): 39. http://dx.doi.org/10.24191/jchs.v5i2.8971.

Full text

Abstract:

Introduction: Hormonal abnormality is one of many clinical manifestations of HIV infections that is not well understood. However, the consequences could affect quality of life and are potentially treatable. Thus, this study aimed to determine the prevalence and associated factors of thyroid, adrenal and gonadal dysfunctions among HIV-infected patients. Methods: This is a single centre cross-sectional study involving 150 HIV-infected patients attending the HIV clinic. Each subject was required to answer specific symptoms questionnaire and their medical records were reviewed for relevant clinica

APA, Harvard, Vancouver, ISO, and other styles

32

Hogan, M. J. S. "Endocrinopathies in Childhood Cancer Survivors." AAP Grand Rounds 36, no. 4 (2016): 41. http://dx.doi.org/10.1542/gr.36-4-41.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Chaudhary, Vikas, and Shahina Bano. "Imaging of pediatric pituitary endocrinopathies." Indian Journal of Endocrinology and Metabolism 16, no. 5 (2012): 682. http://dx.doi.org/10.4103/2230-8210.100635.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Perez, F. A., D. Werny, C. L. Roth, and J. N. Wright. "Neuroimaging Review of Pediatric Endocrinopathies." Neurographics 10, no. 1 (2020): 33–58. http://dx.doi.org/10.3174/ng.1900019.

Full text

Abstract:

The hypothalamic-pituitary axis regulates many important functions in a child, including growth, puberty, and maintenance of physiologic homeostasis. Dysfunction of the hypothalamic-pituitary axis can produce hormone disturbances that result in various pediatric neuroendocrinopathies, including an isolated growth hormone deficiency, multiple pituitary hormone deficiencies, precocious or delayed puberty, central diabetes insipidus, and elevated pituitary hormone conditions (eg, hyperprolactinemia). Although the hormonal abnormalities in a child with endocrinopathy are typically well characteriz

APA, Harvard, Vancouver, ISO, and other styles

35

Zeshan, Muhammad, Sudeshna Basu, Jensi George, Musarrat Riaz, Salma Malik, and Nazish Imran. "Endocrinopathies Due to Psychotropic Agents." Psychiatric Annals 51, no. 9 (2021): 410–15. http://dx.doi.org/10.3928/00485713-20210806-01.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Lu, Difei, and Ying Gao. "Immune checkpoint inhibitor-related endocrinopathies." Journal of Translational Internal Medicine 10, no. 1 (2022): 9–14. http://dx.doi.org/10.2478/jtim-2022-0009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Touheed, Umer, Samra Maryam, Hafiz Muhammad Murtaza, Muhammad Mujtaba Sabir, Lutfullah Goheer, and Aamir Aslam Awan. "Thalassemia ENDOCRINOPATHIES IN THALASSEMIA PATIENTS." PAFMJ 71, no. 6 (2021): 1958–61. http://dx.doi.org/10.51253/pafmj.v6i6.4778.

Full text

Abstract:

Objective: To determine the common endocrine complications found in children having thalassemia major. Study Design: Cross-sectional study. Place and Duration of Study: Department of Pediatric Medicine, Combined Military Hospital Multan, from May to Nov 2019. Methodology: A total of 160 Children with thalassemia were taken in this study. Once registered, venous blood sample was taken and sent to the laboratory for endocrine profile. SPSS-21 was applied for analysis of collected data. Results: Out of 160 study cases, 100 (62.5%) were boys while 60 (37.5%) were female pat

APA, Harvard, Vancouver, ISO, and other styles

38

Al-Agha, Abdulmoein, Noor Bawahab, Sarah Nagadi, Shaimaa Alghamdi, Dalia Felemban, and Asmaa Milyani. "Endocrinopathies complicating transfusion-dependent hemoglobinopathy." Saudi Medical Journal 41, no. 2 (2020): 138–43. http://dx.doi.org/10.15537/smj.2020.2.24845.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Kumar, Vijay, Manoj Rajadhyaksha, and Jacobo Wortsman. "Celiac Disease-Associated Autoimmune Endocrinopathies." Clinical Diagnostic Laboratory Immunology 8, no. 4 (2001): 678–85. http://dx.doi.org/10.1128/cdli.8.4.678-685.2001.

Full text

Abstract:

ABSTRACT Celiac disease (CD) is an autoimmune disorder induced by gluten intake in genetically susceptible individuals. It is characterized by the presence of serum antibodies to endomysium, reticulin, gliadin, and tissue transglutaminase. The incidence of CD in various autoimmune disorders is increased 10- to 30-fold in comparison to the general population, although in many cases CD is clinically asymptomatic or silent. The identification of such cases with CD is important since it may help in the control of type I diabetes or endocrine functions in general, as well as in the prevention of lo

APA, Harvard, Vancouver, ISO, and other styles

40

Usdan, Lisa, Lalita Khaodhiar, and Caroline Apovian. "The Endocrinopathies of Anorexia Nervosa." Endocrine Practice 14, no. 8 (2008): 1055–63. http://dx.doi.org/10.4158/ep.14.8.1055.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Ben Afia, L., N. Ben Salah, D. Afli, et al. "Prurit chronique : rôle des endocrinopathies." Annales d'Endocrinologie 85, no. 5 (2024): 518. http://dx.doi.org/10.1016/j.ando.2024.08.452.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Kira, Jun-ichi, and Yuji Kawano. "Recurrent optic neuromyelitis with endocrinopathies." Neurology 49, no. 5 (1997): 1475.2–1475—a. http://dx.doi.org/10.1212/wnl.49.5.1475-a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Vernant, Jean-Claude, and Charles Poser. "Recurrent optic neuromyelitis with endocrinopathies." Neurology 49, no. 5 (1997): 1475.3–1476. http://dx.doi.org/10.1212/wnl.49.5.1475-b.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Davies, Joshua, and Gerard M. Doherty. "Parathyroid surgery for inherited endocrinopathies." Operative Techniques in Otolaryngology-Head and Neck Surgery 27, no. 3 (2016): 162–66. http://dx.doi.org/10.1016/j.otot.2016.06.010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Rose, Susan R. "Endocrinopathies in Childhood Cancer Survivors." Endocrinologist 13, no. 6 (2003): 488–95. http://dx.doi.org/10.1097/01.ten.0000098611.49230.10.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Lubis, D. A., and E. M. Yunir. "Endocrinopathies in thalassemia major patient." IOP Conference Series: Earth and Environmental Science 125 (March 2018): 012174. http://dx.doi.org/10.1088/1755-1315/125/1/012174.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Anderson, C. Joe. "ENDOCRINOPATHIES MASQUERADING AS ALLERGIC DISEASES." Immunology and Allergy Clinics of North America 16, no. 1 (1996): 107–17. http://dx.doi.org/10.1016/s0889-8561(05)70238-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Hallab, L., L. Hallab, F. Louda, A. Chadli, H. Ghomari, and A. Farouqui. "P232 Diabète secondaire aux endocrinopathies." Diabetes & Metabolism 36 (March 2010): A93. http://dx.doi.org/10.1016/s1262-3636(10)70380-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Sebaitre, N., F. Amghar, F. Kabbaj, and G. Belmejdoub. "P1039 Diabète secondaire aux Endocrinopathies." Diabetes & Metabolism 39 (March 2013): A41. http://dx.doi.org/10.1016/s1262-3636(13)71785-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Lemaire, Antoine. "Endocrinopathies, maladies métaboliques et sexualité." La Presse Médicale 43, no. 10 (2014): 1089–96. http://dx.doi.org/10.1016/j.lpm.2014.07.013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!